Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, October 28 at 2:00 PM ET

Register Free →

This Combined Synopsis/Solicitation opportunity from Department Of Health And Human Services was posted on August 26, 2026. The submission period has ended. Browse the details below for market research, or find similar active opportunities.

Market forecast analyses for West Nile virus (WNV) vaccine and anti-WNV monoclonal antibody for prophylaxis

Closed
97469Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

Active Opportunities Like This One

AI Contract Overview

Show more

The Centers for Disease Control and Prevention (CDC), through the National Center for Emerging and Zoonotic Infectious Diseases, is soliciting quotations for Request for Quotation (RFQ) No. 75D301-26-Q-79208. The objective is to acquire two comprehensive market forecast analyses focusing on a human West Nile virus (WNV) vaccine and an anti-WNV monoclonal antibody for seasonal pre-exposure prophylaxis. This acquisition will be awarded as a Time-and-Materials (T&M) purchase order with a 12-month period of performance from September 30, 2026, to September 29, 2027. The scope of work includes epidemiologic data synthesis, health economic modeling, stakeholder engagement via structured interviews, and the preparation of peer-reviewed publications to disseminate findings to the scientific community. The award will be based on the best-value procurement process, where technical approach, management approach, organizational experience, and past performance are significantly more important than price. Technical evaluation will focus on the contractor's ability to develop transparent forecasting models and integrate complex clinical, commercial, and policy data. Required labor categories for the T&M contract include a Principal Investigator, Postdoctoral Fellow, Health Economist, and Research Analyst. Offerors must provide a completed pricing schedule, written acknowledgement of the Statement of Work, and proof of active SAM registration. All quotes must be submitted to the contracting specialist by September 2, 2026, at 10:00 AM EST.

General Info

CDC seeks market forecast analyses for West Nile virus vaccine and antibody treatments.

NAICS

541715 - Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

Place of Performance

Atlanta, GA, 30341, USA

Set-Aside

NONE

Documents

2

RFQ 75D301-26-Q-79208 Market Forecast Analyses for West Nile Virus

DOC, High priority: read this firstrfq
High

97469 Market Forecast WNV Q&A

DOCX, Medium priorityq-and-a
Medium

AI Contract Breakdown

Uniform Contract Format

Sign up to view the full breakdown with detailed analysis of each section.

Timeline

2 updates
PhaseClosed
Posted

Combined Synopsis

Notice updated

Response deadline changed from Aug 26, 2026 to Sep 2, 2026. The notice description changed.

Notice updated

The notice description changed.

Response Deadline

Deadline has passed

Submission Closed

Find active opportunities like this

Start your free trial to discover similar active contracts, track opportunities, and build proposals with AI assistance.

Organization & Contact Information

Show more
AgencyDepartment Of Health And Human Services → CDC Office Of Acquisition Services
Contacts1 person available
OfficeATLANTA, GA, 30333, USA
Office AddressATLANTA, GA, 30333, USA
Contacts
Iris Gonzalez

Full Description

Show more

Q&A document added.


Due Date for all quotes has been updated to September 2, 2026 at 10am est.


This is a combined synopsis/solicitation for commercial services prepared in accordance with the format prescribed in FAR Subpart 12.6, as supplemented with additional information included in this notice. This announcement constitutes the only solicitation. Quotations are being requested, and a separate written solicitation will not be issued.


The Centers for Disease Control and Prevention (CDC) is issuing Request for Quotation (RFQ) No. 75D301-26-Q-79208 using the procedures of FAR Part 12, Acquisition of Commercial Products and Commercial Services, in conjunction with FAR Part 13, Simplified Acquisition Procedures, for the acquisition of Market Forecast Analyses for West Nile Virus (WNV) Vaccine and Anti-WNV Monoclonal Antibody for Prophylaxis. The acquisition will result in the award of a Time-and-Materials (T&M) purchase order.


Description of Requirement


The Centers for Disease Control and Prevention (CDC), National Center for Emerging and Zoonotic Infectious Diseases (NCEZID), Division of Vector-Borne Diseases (DVBD), requires contractor support to conduct two comprehensive market forecast analyses:


  • Human West Nile virus (WNV) vaccine
  • Anti-WNV monoclonal antibody (mAb) for seasonal pre-exposure prophylaxis

The contractor shall perform market forecasting, epidemiologic analyses, health economic modeling, stakeholder engagement, commercial assessments, financial analyses, and preparation of peer-reviewed publications in accordance with the attached Statement of Work (SOW).


Product or Service Code: AN11 – Health R&D Services, Epidemiology


NAICS Code: 541715- Research and Development in the Physical Engineering, and Life Sciences


Period of Performance: September 30, 2026 – September 29, 2027 (12 months).


Delivery


Services shall be performed in accordance with the attached Statement of Work. Deliverables shall be submitted in accordance with the deliverable schedule identified in Section 7 of the Statement of Work. Monthly invoicing is required.



Submission Requirements


Offerors shall submit the following:


  • Completed pricing for all CLINs.
  • A Time-and-Materials quotation for the entire period of performance.
  • Written acknowledgement of the Statement of Work confirming the ability to perform the required services.
  • Active System for Award Management (SAM) registration, including UEI, with no active exclusions.
  • Any required Artificial Intelligence (AI) disclosures and AI Compliance and Risk Management Plan, if applicable.

More opportunities from Department Of Health And Human Services → CDC Office Of Acquisition Services

Same awarding agency

NAICS: 561499
New
Federal
NCHS/Division of Vital Statistics Coding of the Vital Statistics Data
Solicitation # CDC-NCHS-2027-10162026
The Centers for Disease Control and Prevention, through the National Center for Health Statistics Division of Vital Statistics, is conducting market research to identify qualified sources for information management services. The primary objective is the manual coding of causes of death on mortality and fetal death records for the National Vital Statistics System, specifically targeting records that cannot be processed electronically. The scope includes quality control, automated-system validation, and the use of ICD-based procedures. This effort falls under NAICS code 561499 and is currently in the sources sought phase to determine the appropriate acquisition strategy, which may include various small-business set-asides. The requirement demands high-volume coding capacity, with an expected monthly volume of 25,000 to 45,000 records and a strict quality threshold requiring an error rate below four percent per coder. Qualified providers must supply NCHS-certified nosologists or similarly qualified medical coders and demonstrate the ability to begin performance within one week of award. Performance is expected to occur primarily via remote telework during standard weekday business hours. Due to the sensitive nature of the data, contractors must comply with FIPS 199, Executive Order 13556 regarding Controlled Unclassified Information, and the HHS Information Security Program, utilizing government-furnished equipment and PIV cards for secure network access.
All Other Business Support Services

POSTED

5 days ago

DEADLINE

in 1 day
View Details
NAICS: 541990
New
Federal
Dose Reconstruction and Related Activities to Support NIOSH's Responsibilities under the Energy Employees Occupational Illness Compensation Act (EEOICPA)
Solicitation # 0000HCCN-2027-99582
The Centers for Disease Control and Prevention, on behalf of the National Institute for Occupational Safety and Health, is seeking offers for a contract to provide dose reconstruction and related activities supporting the Energy Employees Occupational Illness Compensation Act. The selected contractor will support the Division of Compensation Analysis and Support by performing radiation dose reconstructions for Department of Labor claims and evaluating Special Exposure Cohort petitions. Key responsibilities include data identification, claimant communications, dose estimation, technical program management, and the modernization of systems through cloud migration. This unrestricted competitive acquisition is expected to be a Cost Plus Award Fee contract with a base period from March 1, 2027, to February 29, 2028, and four subsequent twelve-month option periods ending February 28, 2032. Work will be performed at the contractor's facility. Personnel must meet strict security requirements, including background investigations for Level 5C Moderate Risk positions and Department of Energy Q clearances for specific staff. The solicitation is anticipated to be issued in November 2026.
All Other Professional, Scientific, and Technical Services

POSTED

7 days ago

DEADLINE

in 9 days
View Details
NAICS: 541690
Federal
Safety, Prevention, Epidemiology, and Education Development for Health Care and Antimicrobial Resistance - SPEED 2027-2032
Solicitation # 75D301-27-R-73532
The Centers for Disease Control and Prevention intends to establish a new Indefinite-Delivery/Indefinite-Quantity contract vehicle titled Safety, Prevention, Epidemiology, and Education Development for Health Care and Antimicrobial Resistance (SPEED). This vehicle will replace the existing SHEPheRD program to provide as-needed research and technical support in healthcare epidemiology, health behavior, and healthcare-associated infections. The anticipated period of performance is 60 months, running from March 30, 2027, to March 29, 2032, with the solicitation expected to be released by November 16, 2026. The contract is organized into five functional domains: domestic antimicrobial resistance and infection control, healthcare IT and data solutions, global antimicrobial resistance services, emergency preparedness and resilience, and workforce training and message development. Small business set-asides apply across all domains, with Domains 1 through 4 being partial set-asides and Domain 5 being a total set-aside. Relevant NAICS codes include 541690, 541715, and 611430. Offerors may bid on one or more domains and will be evaluated based on their technical approach, staffing, management, experience, price, and past performance.
Other Scientific and Technical Consulting Services

POSTED

13 days ago

DEADLINE

in 18 days
View Details

Find Active Opportunities Like This

Get AI-powered intelligence on the opportunities still open

Every page of the solicitation package shredded into a compliance breakdown

AI-powered matching based on your capabilities and past performance

Competitor and incumbent history on the requirement

Automated alerts on amendments, Q&A deadlines, and award

Miguel
Hillary
Keith Deutsch
Christine

Join 750+ contractors already using CLEATUS